Walleye Capital LLC Eye Point Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$8.16 - $22.89 $1.53 Million - $4.28 Million	187,016 Added 100.03%	373,974 $3.25 Million
Q1 2024 May 15, 2024	BUY	$19.93 - $29.71 $3.73 Million - $5.55 Million	186,958 New	186,958 $3.86 Million
Q1 2023 May 15, 2023	SELL	$2.28 - $5.04 $41,010 - $90,654	-17,987 Reduced 25.59%	52,289 $153,000
Q4 2022 Feb 14, 2023	BUY	$2.37 - $7.2 $166,554 - $505,987	70,276 New	70,276 $245,000

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $357M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.